Attached files
| file | filename |
|---|---|
| 10-Q - 10-Q - Artemis Therapeutics, Inc. | zk1109866.htm |
| EX-31.1 - EXHIBIT 31.1 - Artemis Therapeutics, Inc. | exhibit_31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Artemis Therapeutics, Inc. | exhibit_31-2.htm |
EXHIBIT 32.1
CERTIFICATION OF PRINCIPAL EXECUTIVE AND FINANCIAL OFFICERS
PURSUANT TO U.S.C. SEC. 1350
Each of the undersigned officers of InkSure Technologies Inc., a Delaware corporation (the "Company"), does hereby certify, to such officer's knowledge:
|
|
(i)
|
That the Quarterly Report for the fiscal quarter ended March 31, 2011 (the "Form 10-Q") of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
|
|
(ii)
|
The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
Dated: May 16, 2011
|
/s/ Tal Gilat
|
||
|
Tal Gilat, President and Chief Executive Officer
|
|||
|
(Principal Executive Officer)
|
|||
|
Dated: May 16, 2011
|
/s/ David (Dadi) Avner
|
||
|
David (Dadi) Avner, Chief Financial Officer
|
|||
|
(Principal Financial Officer)
|
|||